Risk factor | Defining measure NCEP-ATP III | Defining measure AHA/NHLB |
---|---|---|
Abdominal obesity (waist circumference) | Â | Â |
Men | > 102 cm | ≥ 102 cm |
Women | > 88 cm | ≥ 88 cm |
Triglycerides | ≥ 150 mg/dL | ≥ 150 mg/dL or on drug treatment for elevated triglycerides |
High density lipoprotein (HDL) | Â | Â |
Men | < 40 mg/dL | < 40 mg/dL or on drug treatment for reduced HDL-cholesterol |
Women | < 50 mg/dL | < 50 mg/dL or on drug treatment for reduced HDL-cholesterol |
Blood pressure | Systolic ≥ 130 or diastolic ≥ 85 mmHg | Systolic ≥ 130 or diastolic ≥ 85 mmHg or on antihypertensive medication |
Fasting glucose | ≥ 110 mg/dL | ≥ 100 mg/dL or on antidiabetic medication |